Medibio Company Top Insiders
| MDBIF Stock | USD 0.02 0.00 0.00% |
Medibio employs about 28 people. The company is managed by 10 executives with a total tenure of roughly 66 years, averaging almost 6.0 years of service per executive, having 2.8 employees per reported executive. Examination of Medibio's management performance can provide insight into the company performance.
| Josh Purdy Insider PR Director |
| Matthew Flax Insider Head Team |
Medibio |
Medibio Management Team Effectiveness
The company has return on total asset (ROA) of (0.1292) % which means that it has lost $0.1292 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0812) %, meaning that it generated substantial loss on money invested by shareholders. Medibio's management efficiency ratios could be used to measure how well Medibio manages its routine affairs as well as how well it operates its assets and liabilities.Medibio Workforce Comparison
Medibio Limited is considered to be number one stock in number of employees category among its peers. The total workforce of Health Information Services industry is now estimated at about 85.0. Medibio totals roughly 28.0 in number of employees claiming about 33% of equities under Health Information Services industry.
Medibio Limited Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Medibio Limited Price Series Summation is a cross summation of Medibio price series and its benchmark/peer.
Medibio Notable Stakeholders
A Medibio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medibio often face trade-offs trying to please all of them. Medibio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medibio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Josh Purdy | PR Director | Profile | |
| Matthew Flax | Head Team | Profile | |
| Stephanie Ottens | Investor Director | Profile | |
| Michael Player | Head Research | Profile | |
| Archie MD | Chief Officer | Profile | |
| Massimiliano Grassi | Head Intelligence | Profile | |
| Jennifer Solitario | Sr Health | Profile | |
| Mathew CA | Company Sec | Profile | |
| Renee StantonHorne | Operations Mang | Profile | |
| Thomas MD | Chief Officer | Profile |
About Medibio Management Performance
The success or failure of an entity such as Medibio Limited often depends on how effective the management is. Medibio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medibio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medibio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Medibio Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. Medibio Limited was incorporated in 1987 and is headquartered in Melbourne, Australia. Medibio operates under Health Information Services classification in the United States and is traded on OTC Exchange.
Medibio Workforce Analysis
Traditionally, organizations such as Medibio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medibio within its industry.Medibio Manpower Efficiency
Return on Medibio Manpower
| Revenue Per Employee | 1.4K | |
| Revenue Per Executive | 4K | |
| Net Loss Per Employee | 454.1K | |
| Net Loss Per Executive | 1.3M |
Complementary Tools for Medibio Pink Sheet analysis
When running Medibio's price analysis, check to measure Medibio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibio is operating at the current time. Most of Medibio's value examination focuses on studying past and present price action to predict the probability of Medibio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibio's price. Additionally, you may evaluate how the addition of Medibio to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |